Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Brittney Fontana"'
Autor:
Eudocia Q. Lee, Alona Muzikansky, Dan G. Duda, Sarah Gaffey, Jorg Dietrich, Lakshmi Nayak, Ugonma N. Chukwueke, Rameen Beroukhim, Lisa Doherty, Caroline Kane Laub, Debra LaFrankie, Brittney Fontana, Jennifer Stefanik, Sandra Ruland, Victoria Caruso, Jennifer Bruno, Keith Ligon, David A. Reardon, Patrick Y. Wen
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5988-5994 (2019)
Abstract Background Responses to bevacizumab in glioblastoma (GBM) are not durable. Plasma levels of basic fibroblast growth factor (bFGF) increase at the time of tumor progression. By targeting vascular endothelial growth factor receptor (VEGFR), pl
Externí odkaz:
https://doaj.org/article/57064c00cd29451f907052cc6b3f6e14
Autor:
Jennifer Bruno, Jennifer Stefanik, Sarah C. Gaffey, Brittney Fontana, David A. Reardon, Sandra Ruland, Ugonma Chukwueke, Eudocia Q. Lee, Keith L. Ligon, Dan G. Duda, Debra LaFrankie, Caroline Kane Laub, Rameen Beroukhim, Alona Muzikansky, Patrick Y. Wen, Victoria Caruso, Jorg Dietrich, Lakshmi Nayak, Lisa Doherty
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5988-5994 (2019)
Cancer Medicine
Cancer Medicine
Background Responses to bevacizumab in glioblastoma (GBM) are not durable. Plasma levels of basic fibroblast growth factor (bFGF) increase at the time of tumor progression. By targeting vascular endothelial growth factor receptor (VEGFR), platelet‐
Autor:
Debra LaFrankie, Jorg Dietrich, Dan G. Duda, Rameen Beroukhim, Sarah C. Gaffey, Alona Muzikansky, Lisa Doherty, Brittney Fontana, Lakshmi Nayak, Sandra Ruland, Caroline Kane, Jennifer Bruno, Patrick Y. Wen, Victoria Caruso, Jennifer Stefanik, Eudocia Q. Lee, David A. Reardon, Ugonma Chukwueke
Publikováno v:
Journal of Clinical Oncology. 36:2032-2032
2032Background: Responses to bevacizumab in recurrent glioblastoma (GBM) are not durable. Plasma levels of basic fibroblast growth factor (bFGF) increase at the time of tumor progression. By concom...